Seattle Genetics pulls out of $2 billion bid for cancer drug

Bothell-based Seattle Genetics, the region’s biggest biotech firm, spiked a $2 billion deal to manfuacture and distribute an experimental tumor fighting drug.

The company announced in February that it had reached a deal with New Jersey-based Immunomedics for exclusive worldwide rights to develop IMMU-132, which could fight tumors in breast, lung and bladder cancers. Seattle Genetics agreed to pay $250 million upfront, with licensing payments potentially reaching as much as $2 billion.

A large shareholder in Immunomedics, venBio Select Advisor thought the deal undervalued the anti-cancer drug. In March, it filed a lawsuit to block the agreement.

Last week, shareholders led by venBio ousted the husband-and-wife team leading Immunomedics and approved a plan for the company to make and distribute IMMU-132.

The deal would be “nice to have,” but is “not a must have,” Seattle Genetics’ chief operating officer Eric Dobmeier said, according to Seeking Alpha, an investment news website.

Seattle Genetics has grown substantially in recent years, and expects to grow further in the next few years.

The company will focus its “full attention and resources to our promising pipeline and the substantial opportunities in front of us,” chief executive officer Clay Siegall said.

Its current product, Adcetris, could soon become a go-to drug for treating one of the main types of lymphoma. Seattle Genetics expects to bring several drugs to market in the next few years. The company plans to add 200 employees this year, raising its workforce to more than 1,100.

Dan Catchpole: 425-339-3454; dcatchpole@heraldnet.com; Twitter: @dcatchpole.

More in Business

CitySurf pop-up pool could open this summer on Eastside

A Sammamish couple hopes to break ground on a permanent indoor surf facility later this year.

Two wineries move in with Teatro ZinZanni

Two local wineries will be sharing the old Redhook brewery in Woodinville with Teatro ZinZanni.

Real estate embraces the digital era in creative ways

Kirkland’s MainStreet Property Group’s Junction Apartments in downtown Bothell topic of discussion at recent real estate symposium.

Office space is tight all across the Eastside

The Broderick Group released a report detailing low office vacancy rates across Eastside cities.

Local pot stores bringing in the green

Bothell’s marijuana retail stores have done well recently.

Country Village businesses face an uncertain future

Country Village will be open for another year, but business owners are thinking of the future.

Solar business moves in to Kenmore

Northwest Electric and Solar is open for business in Kenmore following a move from Seattle.

AGC Biologics appoints new head of Bothell operations

Jin Wang, Ph.D. was named site head general manager.

Ivar’s and Kidd Valley hold annual Teacher of the Year contest

The fifteenth annual contest awards two teachers with $500 in supplies and a party for their class.

Seaplane Kitchen and Bar broke ground early this year and plans to complete construction in the fall. Photo by Kailan Manandic, Bothell/Kenmore Reporter
Seaplane construction takes off

The downtown Kenmore restaurant plans to open this fall.

New Crossroad SIGN studio opens with free e-book offer

The company has opened a new studio on 164th Ave.

Loftium business model helps make homeowning feasible

The Seattle-based startup launched its work in Bothell last month.